Bristol Myers Squibb has moved to take full control of the CAR-T therapy it partners with 2seventy bio, agreeing to buy the biotech for around $286 million. The $5.00-per-share offer – announced at ...
Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...
Abstract: Microcontroller-driven battery management systems (BMS) are crucial for various applications, including electric vehicles, portable electronics, and renewable energy storage. These systems ...
Of the 13 programs that the companies will advance, four will come from Hengrui Pharma and four from Bristol Myers Squibb. The remaining five assets will be jointly discovered. Bristol Myers Squibb ...
BMS' first-quarter revenues climbed 3% to $11.5 billion, with $6.2 billion of the haul coming from its newer growth product portfolio. (Angus Liu/Fierce Pharma) Bristol Myers Squibb’s growth portfolio ...
Lithium-ion batteries are a key enabling technology for electric vehicles (EVs) 1 due to their high energy density, efficiency, and rechargeability. However, their performance and safety are not ...
Nearly 4,500 Tesla Model 3 and Model Y owners in South Korea have complained about battery malfunctions that prevent charging. The problem, which primarily affects 2021 models, has drawn the scrutiny ...
Bristol Myers Squibb is securing an opportunity to compete in the next generation of cell therapies through the $1.5 billion acquisition of Orbital Therapeutics, a startup with a lead program nearing ...
Bristol Myers Squibb, Board Chair of BMS and CEO Christopher Boerner, PhD, have committed the pharma giant to investing $40 billion over the next five years toward U.S. research and development (R&D), ...
The decision has impacted “some of our employees,” a BMS spokesperson said, without disclosing expected layoff numbers. (Bristol Myers Squibb) Roughly two years after securing a former Novartis ...
While it is common to hear that drug developers are in the early stages of integrating artificial intelligence with their drug research, discovery, and development efforts, one Bristol Myers Squibb ...
The world of robotics offers an exciting avenue for exploration and creation, and for those just starting, the prospect of building a functioning robot can be both thrilling and potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results